Clinical Trial Update: Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a treatment for anemia in cancer patients not receiving chemotherapy or radiotherapy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Cancer | Phase 3 | Status: TERMINATED